Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Biomolecules ; 13(1)2023 01 09.
Article in English | MEDLINE | ID: mdl-36671523

ABSTRACT

Gum arabic (GA) is a natural product commonly used as a household remedy for treating various diseases in the Sub-Saharan Africa region. Despite its claimed benefits, there has been a lack of research on the findings of current clinical trials (CTs) that investigated its efficacy in the treatment of various medical diseases. The aim of this systematic review was to study CTs which focused on GA and its possible use in the management of various medical diseases. A search of the extant literature was performed in the PubMed, Scopus, and Cochrane databases to retrieve CTs focusing on evidence-based clinical indications. The databases were searched using the keywords ("Gum Arabic" OR "Acacia senegal" OR "Acacia seyal" OR "Gum Acacia" OR "Acacia Arabica") AND ("Clinical Trial" OR "Randomized Controlled Trial" OR "Randomized Clinical Trial"). While performing the systematic review, data were obtained on the following parameters: title, authors, date of publication, study design, study aim, sample size, type of intervention used, targeted medical diseases, and main findings. Twenty-nine papers were included in this systematic review. The results showed that ingestion of GA altered lipid profiles, renal profiles, plaque, gingival scores, biochemical parameters, blood pressure, inflammatory markers, and adiposity. GA exhibited anti-inflammatory, prebiotic, and antibacterial properties. GA has been successfully used to treat sickle cell anemia, rheumatoid arthritis, metabolic disorders, periodontitis, gastrointestinal conditions, and kidney diseases. Herein, we discuss GA with respect to the underlying mechanisms involved in each medical disease, thereby justifying GA's future role as a therapeutic agent.


Subject(s)
Acacia , Gum Arabic , Gum Arabic/therapeutic use , Acacia/chemistry , Anti-Inflammatory Agents , Adiposity , Blood Pressure
2.
Molecules ; 27(4)2022 Feb 09.
Article in English | MEDLINE | ID: mdl-35208961

ABSTRACT

Acacia seyal is an important source of gum Arabic. The availability, traditional, medicinal, pharmaceutical, nutritional, and cosmetic applications of gum acacia have pronounced its high economic value and attracted global attention. In addition to summarizing the inventions/patents applications related to gum A. seyal, the present review highlights recent updates regarding its phytoconstituents. Traditional, cosmetic, pharmaceutical, and medicinal uses with the possible mechanism of actions have been also reviewed. The patent search revealed the identification of 30 patents/patent applications of A. seyal. The first patent related to A. seyal was published in 1892, which was related to its use in the prophylaxis/treatment of kidney and bladder affections. The use of A. seyal to treat cancer and osteoporosis has also been patented. Some inventions provided compositions and formulations containing A. seyal or its ingredients for pharmaceutical and medical applications. The inventions related to agricultural applications, food industry, cosmetics, quality control of gum Arabic, and isolation of some chemical constituents (L-rhamnose and arabinose) from A. seyal have also been summarized. The identification of only 30 patents/patent applications from 1892 to 15 November 2021 indicates a steadily growing interest and encourages developing more inventions related to A. seyal. The authors recommend exploring these opportunities for the benefit of society.


Subject(s)
Acacia/chemistry , Cosmetics , Gum Arabic , Phytochemicals , Cosmetics/chemistry , Cosmetics/therapeutic use , Gum Arabic/chemistry , Gum Arabic/therapeutic use , Humans , Patents as Topic , Phytochemicals/chemistry , Phytochemicals/therapeutic use
3.
Trials ; 21(1): 766, 2020 Sep 05.
Article in English | MEDLINE | ID: mdl-32891160

ABSTRACT

OBJECTIVES: To investigate the potential efficacy of Acacia Senegal extract Gum Arabic (GA) supplementation as immunomodulatory and anti-inflammatory dietary intervention among newly diagnosed COVID 19 Sudanese patients. To study the effect of GA on the level of cytokines, TNFα, IL8, IL6 IL10, CRP and the viral load. Secondary outcomes will be the effect of GA oral intake on mortality rate and days of hospital admission. TRIAL DESIGN: Quadruple blind, randomized placebo-controlled clinical trial Phase II & III. Prospective, two-arm, parallel-group, randomised (1:1 allocation ratio) superiority trial of oral GA among seropositive COVID-19 patients. PARTICIPANTS: Inclusion criteria: COVID-19 infected (newly diagnosed) as proved by real-time PCR within 72 hours of PCR. Age 8-90 years Both genders Exclusion criteria: Intubated patients on parenteral treatment Allergy to Gum Arabic The study will be conducted in COVID Isolation Centres and Soba University Hospital Khartoum State Sudan. INTERVENTION AND COMPARATOR: Experimental: Intervention Group This arm will receive 100% natural Gum Arabic provided in a powder form in 30-grams-dose once daily for four weeks Placebo Comparator: Control group: This group will be provided with pectin powder provided as one-gram-dose once daily for four weeks Both GA and placebo will be in addition to standard care treatment based on local clinical guidelines. MAIN OUTCOMES: Mean change from baseline score of Immune Response to end of the trial. Changes of the level of Tumor Necrosis Factor (TNFα), interleukin IL8, IL6, and IL10 from the baseline values (Four weeks from the start of randomization). Mortality rate: The percentage of deaths among COVID 19 patients received Gum Arabic compared to placebo (Four weeks from the start of randomization]). RANDOMISATION: Randomization (1:1 allocation ratio) and will be conducted using a sequence of computer-generated random numbers by an independent individual. Each participating centre will be assigned a special code generated by the computer. The randomization will be kept by the PI and a research assistant. BLINDING (MASKING): Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) NUMBERS TO BE RANDOMISED (SAMPLE SIZE): 110 eligible patients will be randomly assigned to either GA (n=55) or placebo (n=55) groups. TRIAL STATUS: Protocol Version no 2, 30th June 2020. Recruitment will start on 15th September 2020. The intended completion date is 15th January 2021. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04381871 . Date of trial registration: 11 May 2020. FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.


Subject(s)
Betacoronavirus/drug effects , Coronavirus Infections/drug therapy , Gum Arabic/therapeutic use , Immunologic Factors/therapeutic use , Pneumonia, Viral/drug therapy , Adolescent , Adult , Aged , Aged, 80 and over , Betacoronavirus/immunology , Betacoronavirus/pathogenicity , COVID-19 , Child , Clinical Trials, Phase II as Topic , Clinical Trials, Phase III as Topic , Coronavirus Infections/diagnosis , Coronavirus Infections/immunology , Coronavirus Infections/virology , Female , Gum Arabic/adverse effects , Host Microbial Interactions , Humans , Immunologic Factors/adverse effects , Male , Middle Aged , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/immunology , Pneumonia, Viral/virology , Prospective Studies , Randomized Controlled Trials as Topic , SARS-CoV-2 , Time Factors , Treatment Outcome , Young Adult , COVID-19 Drug Treatment
4.
Biomolecules ; 10(5)2020 05 13.
Article in English | MEDLINE | ID: mdl-32414135

ABSTRACT

We investigated some reproductive actions of hookah smoke (HS) exposure (30 min/day, for 30 days) in male mice, and the possible mitigative effect of the prebiotic agent gum acacia (GA) thereon. Control mice were air-exposed (AE). Twenty-four hours after the last exposure, the levels of some plasma reproductive hormones, biochemical markers of inflammation, oxidative and nitrosative stress and testicular histopathology were assessed. The urinary level of cotinine, a major nicotine metabolite, was also measured. HS exposure induced significant decreases in testosterone, estradiol, luteinizing hormone, and androgen binding protein, as well as glutathione reductase activity and levels of nitrite and total nitrite. Plasma inhibin B, alkaline phosphatase, lipopolysaccharide binding protein, uric acid, lactate dehydrogenase, lipid peroxidation, 8-oxo-2'-deoxyguanosine, and cytochrome C were significantly increased following HS exposure. In testicular homogenate, nuclear factor-κB (NF-ĸB), nuclear factor erythroid 2-related factor 2 (Nrf2), interleukin- 6 (IL-6), interleukin-1ß (IL-1ß), transforming growth factor-ß1(TGF- ß1), and tumor necrosis factor-α (TNF- α) were all significantly elevated, and the steroidogenic acute regulatory protein (StAR) significantly decreased. Histopathologically, there was slight impairment and disorganization of spermatogenesis. Urinary cotinine concentration was elevated significantly in the HS-exposed group compared with the air-exposed group. GA co-administration mitigated the adverse actions of HS measured. In conclusion, daily exposure to HS at the above dose induced adverse actions on the reproductive system of male mice. GA co-administration significantly mitigated these effects by reducing the inflammation, oxidative and nitrosative stress, via a mechanism involving Nrf2, and reduction of StAR expression.


Subject(s)
Gum Arabic/pharmacology , Testicular Diseases/prevention & control , Testis/drug effects , Tobacco Smoke Pollution/adverse effects , Tobacco, Waterpipe/adverse effects , Animals , Gonadal Hormones/blood , Gum Arabic/therapeutic use , Interleukin-6/metabolism , Male , Mice , Mice, Inbred C57BL , NF-E2-Related Factor 2/metabolism , NF-kappa B/metabolism , Oxidative Stress , Phosphoproteins/metabolism , Spermatogenesis , Testicular Diseases/etiology , Testis/metabolism , Testis/pathology , Tumor Necrosis Factor-alpha/metabolism
5.
Oxid Med Cell Longev ; 2019: 8526083, 2019.
Article in English | MEDLINE | ID: mdl-31178975

ABSTRACT

The prevalence of waterpipe (shisha) tobacco smoking has recently seen a substantial increase worldwide and is becoming a public health problem. Both human and animal studies have established that waterpipe smoke (WPS) increases airway reactivity and inflammation. Gum Arabic (GA) is a prebiotic agent that possesses antioxidant and anti-inflammatory properties. However, its effects on lung toxicity induced by WPS exposure are unknown. Thus, the aim of this study was to investigate the possible salutary effects and underlying mechanisms of GA on WPS-induced pulmonary pathophysiologic effects. C57BL/6 mice were exposed to air or WPS (30 minutes/day for one month) with or without GA treatment in drinking water (15%, w/v). Exposure to WPS induced an influx of neutrophil polymorphs in the peribronchiolar and interstitial spaces and an increase of tumor necrosis factor-α and 8-isoprostane, a marker of lipid peroxidation, concentrations in lung homogenates. The latter effects were significantly mitigated by GA treatment. Likewise, the lung DNA damage induced by WPS exposure was prevented by GA administration. Western blot analysis of the lung showed that GA inhibited nuclear factor kappa-B (NF-κB) expression caused by WPS and augmented that of nuclear factor erythroid 2-related factor 2 (Nrf2). Similarly, immunohistochemical analysis of bronchial epithelial cells and alveolar cells showed a parallel and significant increase in the nuclear expression of Nrf2 and cytoplasmic expression of glutathione in mice treated with GA and exposed to WPS. Moreover, GA administration has significantly prevented airway hyperreactivity to methacholine induced by WPS. We conclude that GA administration significantly declined the physiological, histological, biochemical, and molecular indices of lung toxicity caused by WPS exposure, indicating its beneficial respiratory impact. Considering that GA is a safe agent with health benefits in humans, our data suggest its potential usage in waterpipe smokers.


Subject(s)
Gum Arabic/therapeutic use , Lung Injury/etiology , Smoke/adverse effects , Smoking Water Pipes/standards , Animals , Gum Arabic/pharmacology , Lung Injury/pathology , Mice
6.
Life Sci ; 219: 294-302, 2019 Feb 15.
Article in English | MEDLINE | ID: mdl-30668954

ABSTRACT

AIMS: Exogenous tetrahydrobiopterin (BH4), an indispensable cofactor of endothelial nitric oxide synthase (eNOS), supplementation has been proved to be of advantage to improve cardiovascular function. Nevertheless, due to its highly redox-sensitive and easy to be oxidized, there is an urgent need to develop an appropriate BH4 formulation for clinical therapy. Gum Arabic (GA) has been considered as an alternative biopolymer for the stabilization and coating of drugs. The effects of GA on protecting BH4 from being oxidized were investigated in a rat model of myocardial ischemia-reperfusion (I/R). MAIN METHODS: Rats were subjected to 60-min of in vivo left coronary artery occlusion and varying periods of reperfusion with or without pre-ischemic GA-coated BH4 supplementation (10 mg/kg, oral). Myocardial infarction, fibrotic area and left ventricle ejection fraction were correlated with cardiac BH4 content, eNOS protein, NOS enzyme activity, and ROS/NO generation. KEY FINDINGS: Pretreatment of rats with GA-coated 6R-BH4, 24 h before myocardial ischemia, resulted in smaller myocardial infarction, improved left ventricular function and inhibited fibrosis, correlated with maintained high levels of cardiac BH4 content, preserved eNOS activation and dimerization, and decreased ROS generation. However in uncoated group, 6R-BH4 treatment did not reduce acute and chronic myocardial I/R injury compared with control I/R rats, which was closely related with the marked loss of myocardial BH4 levels during I/R. SIGNIFICANCE: These findings provide evidence that in vivo pre-ischemic oral GA-coated BH4 administration preserves eNOS function secondary to maintaining cardiac BH4 content, and confers cardioprotection after I/R.


Subject(s)
Biopterins/analogs & derivatives , Cardiotonic Agents/therapeutic use , Gum Arabic/therapeutic use , Myocardial Reperfusion Injury/prevention & control , Nitric Oxide Synthase Type III/metabolism , Animals , Biopterins/administration & dosage , Biopterins/therapeutic use , Cardiotonic Agents/administration & dosage , Chromatography, High Pressure Liquid , Echocardiography , Immunoblotting , Male , Myocardial Reperfusion Injury/diagnostic imaging , Pharmaceutical Vehicles/therapeutic use , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism
7.
Biomolecules ; 9(1)2019 01 11.
Article in English | MEDLINE | ID: mdl-30641998

ABSTRACT

Arabic gum (AG) has antioxidant and anti-inflammatory properties. However, the effect of AG in ureteric obstruction (UO) has not been investigated yet. Male rats underwent reversible left unilateral UO (UUO) for 72 h. Group AG-1 (n = 12) received AG 15 g/kg/day dissolved in drinking water starting seven days before and continuing throughout the period of the UUO, whereas group Vx-1 (n = 8) had only water. Group AG-2 (n = 12) and Vx-2 (n = 8) had similar protocols as AG-1 and Vx-1, respectively, but underwent terminal experiments to measure renal functions, six days post-UUO reversal. Arabic gum significantly attenuated the UUO-induced increase in the tissue level of malonedialdehyde and superoxide dismutase and the rise in the gene expression of TNF-α, TGF-ß1, and p53 in AG-1 compared to Vx-1. It also attenuated the severity of tubular dilatation. However, AG did not affect the alterations in the renal blood flow or glomerular filtration rate. The fractional sodium excretion was lower in AG-2 but did not reach statistical significance (0.40 ± 0.11 vs 0.74 ± 0.12, p = 0.07). AG attenuated the UUO-induced rise in oxidative stress markers and proinflammatory and profibrotic cytokines and the degree of renal tubular dilatation, indicating a protective effect in obstructive nephropathy.


Subject(s)
Antioxidants/pharmacology , Gum Arabic/pharmacology , Kidney/drug effects , Oxidative Stress/drug effects , Ureteral Obstruction/pathology , Animals , Antioxidants/therapeutic use , Gene Expression Regulation/drug effects , Glomerular Filtration Rate , Gum Arabic/therapeutic use , Kidney/metabolism , Kidney/pathology , Male , Malondialdehyde/metabolism , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/metabolism , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Ureteral Obstruction/drug therapy , Ureteral Obstruction/metabolism
8.
Lipids Health Dis ; 17(1): 56, 2018 Mar 20.
Article in English | MEDLINE | ID: mdl-29558953

ABSTRACT

BACKGROUND: There is a strong association between cardiometabolic risk and adipose tissue dysfunction with great consequences on type 2 diabetic patients. Visceral Adiposity Index (VAI) is an indirect clinical marker of adipose tissue dysfunction. Gum Arabic (GA) is a safe dietary fiber, an exudate of Acacia Senegal. Gum Arabic had shown lipid lowering effect in both humans and animals. The aim of this trial was to determine the effect of GA supplementation on anthropometric obesity marker, Visceral Adiposity Index (VAI) and blood pressure in patients with type 2 diabetes mellitus. METHODS: This randomized, double blinded, placebo controlled trial recruited a total of 91 type 2 diabetic patients (73 females, 18 males), age (mean ± SD) 50.09 ± 9.3 years on hypoglycemic agents and were randomly assigned into two groups, either to consume 30 g of GA or 5 g of placebo daily for 3 months. Anthropometric obesity markers were measured and indices were calculated. Blood pressure was measured and high density lipoprotein (HDL) and triglycerides (TG) were determined in fasting blood samples at the start and end of the study period. RESULTS: After intervention, Gum Arabic decreased BMI and VAI significantly (P < 0.05) in GA group by 2 and 23.7% respectively. Body adiposity index significantly decreased by 3.9% in GA group while there were no significant changes in waist circumference or waist-to-hip ratio (WHR). Systolic blood pressure significantly decreased by 7.6% in GA group and by 2.7% in placebo group from baseline with no significant changes in diastolic blood pressure in the two groups. CONCLUSION: Gum Arabic consumption at a dose of 30 g/d for 3 months may play an effective role in preventing weight gain and modulating adipose tissue dysfunction in type 2 diabetic patients, although no effect has been shown in waist-to-hip ratio. TRIAL REGISTRATION: The trial had been registered as prospective interventional clinical trials in the Pan African Clinical Trial Registry (PACTR) PACTR201403000785219 , on 7th March 2014.


Subject(s)
Cardiovascular Diseases/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Gum Arabic/therapeutic use , Adiposity/drug effects , Adult , Blood Pressure/drug effects , Body Mass Index , Cardiovascular Diseases/metabolism , Diabetes Mellitus, Type 2/metabolism , Female , Humans , Hypoglycemic Agents/therapeutic use , Male , Middle Aged
9.
Cell Physiol Biochem ; 45(6): 2293-2304, 2018.
Article in English | MEDLINE | ID: mdl-29550811

ABSTRACT

BACKGROUND/AIMS: The effect of treatment with gum acacia (GA), a prebiotic shown previously to ameliorate chronic kidney disease (CKD), in diabetic and non - diabetic rats with adenine - induced CKD has been investigated using several conventional and novel physiological, biochemical, and histopathological parameters. METHODS: Diabetes mellitus was induced in rats by a single injection of streptozotocin (STZ). Diabetic and non - diabetic rats were randomly divided into several groups, and given either normal food or food mixed with adenine (0.25% w/w, for five weeks) to induce CKD. Some of these groups were also concomitantly treated orally with GA in the drinking water (15% w/w). RESULTS: Rats fed adenine alone exhibited physiological (decreased body weight, increased food and water intake and urine output), biochemical (increase in urinary albumin/creatinine ratio, plasma urea and, creatinine, indoxyl sulfate and phosphorus), inflammatory biomarkers (increased in neutrophil gelatinase-associated lipocalin, transforming growth factor beta -1, tumor necrosis factor alpha, adiponectin, cystatin C and interleukin-1ß), oxidative biomarkers (8-isoprostane, 8 -hydroxy -2-deoxy guanosine), nitrosative stress biomarkers (nitrite and nitrate) and histopathological (increase in tubular necrosis and fibrosis) signs of CKD. STZ - induced diabetes alone worsened most of the renal function tests measured. Administration of adenine in STZ - diabetic rats further worsened the renal damage induced by adenine alone. GA significantly ameliorated the renal actions of adenine and STZ, given either singly or in combination, especially with regards to the histopathological damage. CONCLUSION: GA is a useful dietary agent in attenuating the progression of CKD in rats with streptozotocin-induced diabetes.


Subject(s)
Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/drug therapy , Gum Arabic/therapeutic use , Oxidative Stress/drug effects , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/drug therapy , Acacia/chemistry , Adenine , Animals , Diabetes Mellitus, Experimental/pathology , Disease Models, Animal , Gum Arabic/chemistry , Inflammation/complications , Inflammation/drug therapy , Inflammation/pathology , Kidney/drug effects , Kidney/pathology , Male , Nitrosative Stress/drug effects , Rats , Rats, Wistar , Renal Insufficiency, Chronic/chemically induced , Renal Insufficiency, Chronic/pathology
10.
Indian J Med Res ; 148(6): 743-747, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30778009

ABSTRACT

BACKGROUND & OBJECTIVES: Inflammatory processes are a recognized feature of atherosclerotic lesions. Ranolazine inhibits the inflammatory markers such as C-reactive protein, interleukins-1 and -6 and tumour necrosis factor-alpha. The present study was planned to evaluate the effect of anti-inflammatory activity of ranolazine in acute and sub-acute models of inflammation in rats and compare the same with that of control (gum acacia 1%) and aspirin (standard anti-inflammatory drug). METHODS: Adult male Wistar rats (150-180 g) were used for the study. They were divided into three groups (n=6). One per cent gum acacia (control), aspirin (200 mg/kg body weight) and ranolazine (180 mg/kg body weight) were given orally. Acute inflammation was induced by injecting carrageenan in the left hind paw. Paw oedema volume and percentage inhibition were measured. Subacute inflammation was induced by implanting foreign bodies subcutaneously. Percentage inhibition of granuloma dry weight and haematoxylin and eosin stained sections of granulation tissue were studied. RESULTS: In acute and subacute model study, ranolazine significantly (P <0.01) decreased the paw oedema volume and granuloma dry weight as compared to control and it was comparable to that of aspirin and histopathological sections showed a decrease in granulation tissue formation as compared to control. INTERPRETATION & CONCLUSIONS: Ranolazine demonstrated significant anti-inflammatory activity in acute and subacute models of inflammation and needs further evaluation for its use in reducing atherosclerosis.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Edema/drug therapy , Inflammation/drug therapy , Ranolazine/therapeutic use , Acute Disease , Animals , Aspirin/therapeutic use , Carrageenan , Edema/etiology , Granuloma, Foreign-Body/drug therapy , Granuloma, Foreign-Body/pathology , Gum Arabic/therapeutic use , Inflammation/chemically induced , Inflammation/complications , Male , Random Allocation , Rats, Wistar
11.
Av. odontoestomatol ; 30(6): 299-305, nov.-dic. 2014. ilus, tab
Article in Spanish | IBECS | ID: ibc-132692

ABSTRACT

El objetivo de este trabajo es mostrar diferentes materiales para hacer limpieza bucodental, con alto poder de adsorción, atóxicos y desechables (de usar y tirar), que masticados en la boca permitan arrastrar la placa bacteriana. Material y métodos: Se ha seleccionado información válida para el estudio en la base de datos medline, red de internet y bibliografía de archivos propios. Resultados: Entre los materiales hallados están: las sepiolitas, zeolitas, agares, carbón activo, polímeros de la familia de las gomas y goma arábiga, siliconas, caolín, hojas de té, cenizas de neumáticos y deshechos de plantas modificadas químicamente. Discusión: Sepiolitas y zeolitas podrían incorporarse a gomas -tipo chicle- para ser masticados y luego desechados. Polímeros de la familia de los agares y de la familia de las gomas podrían ser aplicados sobre la superficie dental, de forma que al ser retirado pueda arrastrar la placa dental. Conclusiones: Proponemos una nueva alternativa al cepillado dental, mediante material desechable de gran adsorción, aunque está todavía en fase de estudio y aplicabilidad en estomatología (AU)


The aim of this paper is to show different materials to make oral cleaning, with high adsorption power, non-toxic and disposable (throwaway) which chewed in the mouth allow drag plaque. Material and Methods: valid information has been selected for study in the Medline data base, internet network and bibliography own files. Results: Among the materials are found sepiolites, zeolites, agars, activated carbon, polymers Family gums and gum arabic, silicones, kaolin, tea leaves, tyre ashes and waste of chemically modified plants. Discussion: Sepiolites and zeolites could be incorporated into gums -gum type- to be chewed and then discarded. Family polymers agars and gums may be applied onto the tooth surface, so that upon removal of dental plaque drag. Conclusions: We propose a new alternative to brushing, using disposables high adsorption, although it is still under study and applicability in stomatology (AU)


Subject(s)
Humans , Oral Hygiene/methods , Oral and Dental Hygiene Products , Dental Plaque/drug therapy , Agar/therapeutic use , Chewing Gum , Adsorption , Silicones/therapeutic use , Gum Arabic/therapeutic use , Charcoal/therapeutic use
12.
Int J Nanomedicine ; 9: 5001-11, 2014.
Article in English | MEDLINE | ID: mdl-25378926

ABSTRACT

INTRODUCTION: Gum arabic-coated radioactive gold nanoparticles (GA-(198)AuNPs) offer several advantages over traditional brachytherapy in the treatment of prostate cancer, including homogenous dose distribution and higher dose-rate irradiation. Our objective was to determine the short-term safety profile of GA-(198)AuNPs injected intralesionally. We proposed that a single treatment of GA-(198)AuNPs would be safe with minimal-to-no evidence of systemic or local toxicity. METHODS: Nine dogs with spontaneously occurring prostatic cancer were treated. Injections were performed with ultrasound or computerized tomography guidance. Complete blood counts, chemistry panels, and urinalyses were performed at weekly intervals for 1 month and imaging was repeated 4 weeks postinjection. Planar scintigraphic images were obtained within 30 minutes of injection. RESULTS: No statistically significant difference was found in any hematologic or biochemical parameter studied, nor was any evidence of tumor swelling or abscessation found in eight dogs with repeat imaging; one dog died secondary to urethral obstruction 12 days following injection. At 30 minutes postinjection, an average of 53% of injected dose in seven dogs was retained in the prostate, with loss of remaining activity in the bladder and urethra; no systemic uptake was detected. CONCLUSION: GA-(198)AuNP therapy had no short-term toxicity in the treatment of prostatic cancer. While therapeutic agent was found in the prostate immediately following injection, some loss of agent was detected in the bladder and urethra. Localization of radioactivity within the prostate was lower than anticipated and likely due to normal vestigial prostatic ducts. Therefore, further study of retention, dosimetry, long-term toxicity, and efficacy of this treatment is warranted prior to Phase I trials in men.


Subject(s)
Gold/toxicity , Gum Arabic/toxicity , Metal Nanoparticles/toxicity , Prostatic Neoplasms/radiotherapy , Animals , Brachytherapy , Dogs , Gold/therapeutic use , Gum Arabic/therapeutic use , Male , Metal Nanoparticles/therapeutic use , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/pathology , Prostatic Neoplasms/veterinary , Tomography, X-Ray Computed
13.
PLoS One ; 9(7): e102528, 2014.
Article in English | MEDLINE | ID: mdl-25048380

ABSTRACT

Different modes of exercise are reported to be beneficial in subjects with chronic kidney disease (CKD). Similar benefits have also been ascribed to the dietary supplement gum acacia (GA). Using several physiological, biochemical, immunological, and histopathological measurements, we assessed the effect of swimming exercise (SE) on adenine-induced CKD, and tested whether SE would influence the salutary action of GA in rats with CKD. Eight groups of rats were used, the first four of which were fed normal chow for 5 weeks, feed mixed with adenine (0.25% w/w) to induce CKD, GA in the drinking water (15% w/v), or were given adenine plus GA, as above. Another four groups were similarly treated, but were subjected to SE during the experimental period, while the first four groups remained sedentary. The pre-SE program lasted for four days (before the start of the experimental treatments), during which the rats were made to swim for 5 to 10 min, and then gradually extended to 20 min per day. Thereafter, the rats in the 5th, 6th, 7th, and 8th groups started to receive their respective treatments, and were subjected to SE three days a week for 45 min each. Adenine induced the typical signs of CKD as confirmed by histopathology, and the other measurements, and GA significantly ameliorated all these signs. SE did not affect the salutary action of GA on renal histology, but it partially improved some of the above biochemical and physiological analytes, suggesting that addition of this mode of exercise to GA supplementation may improve further the benefits of GA supplementation.


Subject(s)
Exercise Therapy , Gum Arabic/therapeutic use , Renal Insufficiency, Chronic/therapy , Swimming , Adenine , Animals , Dietary Supplements , Kidney/pathology , Kidney/physiopathology , Male , Rats , Rats, Wistar , Renal Insufficiency, Chronic/chemically induced , Renal Insufficiency, Chronic/pathology , Renal Insufficiency, Chronic/physiopathology , Swimming/physiology
14.
Physiol Res ; 63(3): 351-8, 2014.
Article in English | MEDLINE | ID: mdl-24564605

ABSTRACT

Anemia frequently complicates chronic kidney disease (CKD). We investigated here the effect of adenine-induced CKD in rats on erythrocyte count (EC), hematocrit (PCV) and hemoglobin (Hb) concentration, as well as on the activity of L-gamma-glutamyl transferase (GGT) and the concentrations of iron (Fe), transferrin (Tf), ferritin (F), total iron binding capacity (TIBC) / unsaturated iron binding capacity (UIBC) and hepcidin (Hp) in serum and erythropoietin (Epo) in renal tissue. Renal damage was assessed histopathologically, and also by measuring the serum concentrations of the uremic toxin indoxyl sulfate (IS), creatinine, and urea, and by creatinine clearance. We also assessed the influence of concomitant treatment with gum acacia (GA) on the above analytes. Adenine feeding induced CKD, accompanied by significant decreases (P<0.05) in EC, PCV, and Hb, and in the serum concentrations of Fe, Tf, TIBC, UIBC and Epo. It also increased Hp and F levels. GA significantly ameliorated these changes in rats with CKD. A general improvement in the renal status of rats with CKD after GA is shown due to its anti-inflammatory and anti-oxidant actions, and reduction of the uremic toxin IS, which is known to suppress Epo production, and this may be a reason for its ameliorative actions on the indices of anemia studied.


Subject(s)
Anemia/drug therapy , Gum Arabic/therapeutic use , Kidney Failure, Chronic/complications , Phytotherapy , Adenine , Animals , Gum Arabic/pharmacology , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/chemically induced , Male , Random Allocation , Rats, Wistar
15.
Kidney Blood Press Res ; 37(4-5): 269-79, 2013.
Article in English | MEDLINE | ID: mdl-24022265

ABSTRACT

Gum arabic (GA), a water-soluble dietary fiber rich in Ca(2+), Mg(2+) and K(+), is used in Middle Eastern countries for the treatment of patients with chronic kidney disease. Recent animal experiments shed some light into mechanisms involved in the therapeutic action of GA. According to experiments in healthy mice, GA treatment increases creatinine clearance, enhances renal excretion of ADH, Mg(2+) and Ca(2+), decreases plasma phosphate concentration as well as urinary excretion of phosphate and Na(+). In diabetic mice GA treatment increases urinary Ca(2+) excretion, and decreases plasma phosphate concentration, plasma urea concentration, urinary flow rate, natriuresis, phosphaturia, glucosuria, proteinuria as well as blood pressure. Extrarenal effects of GA treatment in mice include decreased expression of intestinal Na(+) coupled glucose carrier SGLT1 with subsequent delay of electrogenic intestinal glucose transport, glucose-induced hyperglycemia, hyperinsulinemia and body weight gain. GA treatment decreases colonic transcription of the angiogenetic factors angiogenin 1, angiogenin 3 and angiogenin 4, of CD38 antigen, aquaporin4, interleukin18, vav-3-oncogene, y(+)-amino acid-transporter, sulfatase1, ubiquitinD and chemokine ligand5. Moreover, GA treatment decreases angiogenin and ß-catenin protein expression. Accordingly, GA treatment counteracts the development of tumors following chemical cancerogenesis. In mouse dendritic cells, antigen-presenting cells linking innate and adaptive immunity, GA treatment modifies maturation and cytokine release. GA treatment further favourably influences the course of murine malaria. The effects of GA treatment on plasma phosphate concentration, blood pressure and proteinuria may prove beneficial in chronic renal failure and diabetic nephropathy. The effect of GA on intestinal glucose transport may be useful in the prophylaxis and treatment of obesity and diabetes, the effect of GA on angiogenin and ß-catenin expression could be exploited for the prophylaxis against colon carcinoma, the effects of GA on angiogenin expression and dendritic cells may be useful in the treatment of inflammatory disease and malaria.


Subject(s)
Blood Pressure/drug effects , Disease Models, Animal , Gum Arabic/pharmacology , Gum Arabic/therapeutic use , Kidney/drug effects , Animals , Blood Pressure/physiology , Humans , Kidney/physiology , Mice , Neoplasms/drug therapy , Neoplasms/metabolism
16.
PLoS One ; 8(2): e55242, 2013.
Article in English | MEDLINE | ID: mdl-23383316

ABSTRACT

Inflammation and oxidative stress are known to be involved in the pathogenesis of chronic kidney disease in humans, and in chronic renal failure (CRF) in rats. The aim of this work was to study the role of inflammation and oxidative stress in adenine-induced CRF and the effect thereon of the purported nephroprotective agent gum arabic (GA). Rats were divided into four groups and treated for 4 weeks as follows: control, adenine in feed (0.75%, w/w), GA in drinking water (15%, w/v) and adenine+GA, as before. Urine, blood and kidneys were collected from the rats at the end of the treatment for analysis of conventional renal function tests (plasma creatinine and urea concentration). In addition, the concentrations of the pro-inflammatory cytokine TNF-α and the oxidative stress markers glutathione and superoxide dismutase, renal apoptosis, superoxide formation and DNA double strand break frequency, detected by immunohistochemistry for γ-H2AX, were measured. Adenine significantly increased the concentrations of urea and creatinine in plasma, significantly decreased the creatinine clearance and induced significant increases in the concentration of the measured inflammatory mediators. Further, it caused oxidative stress and DNA damage. Treatment with GA significantly ameliorated these actions. The mechanism of the reported salutary effect of GA in adenine-induced CRF is associated with mitigation of the adenine-induced inflammation and generation of free radicals.


Subject(s)
Adenine/adverse effects , Gum Arabic/pharmacology , Inflammation/drug therapy , Kidney Failure, Chronic/chemically induced , Oxidative Stress/drug effects , Animals , Creatinine/blood , Gum Arabic/therapeutic use , Histones/metabolism , Immunohistochemistry , Inflammation/etiology , Interleukin-10/blood , Kidney Failure, Chronic/pathology , Phosphoproteins/metabolism , Rats , Urea/blood
17.
Aust Dent J ; 57(3): 312-8, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22924354

ABSTRACT

BACKGROUND: There is a need for an anti-plaque agent that can be used on a daily basis without the side effects of antibacterial chemicals such as chlorhexidine. The present study was designed to evaluate the clinical and microbiologic effects of commercially available gel and powder containing Acacia arabica in subjects with gingivitis. METHODS: One hundred and twenty subjects with chronic generalized gingivitis were selected and randomly divided into four groups: Group 1 - placebo group; Group 2 -Acacia arabica gel group; Group 3 -Acacia arabica powder group; and Group 4 - 1% chlorhexidine gel group. Microbial counts of plaque samples, the gingival index of Loe and Silness and the plaque index were evaluated at baseline, 6 weeks, 12 weeks and 24 weeks. Microbial counts of plaque samples were evaluated at all visits. RESULTS: Acacia arabica gel and powder showed significant clinical improvement in gingival and plaque index scores as compared to a placebo. This improvement was comparable to 1% chlorhexidine gel. The difference between gel and powder with regard to clinical and microbiological parameters was not found to be significant at any time interval. CONCLUSIONS: Both Acacia arabica gel and powder may be useful herbal formulations for chemical plaque control in subjects with gingivitis.


Subject(s)
Anti-Infective Agents, Local/therapeutic use , Dental Plaque/drug therapy , Gingivitis/drug therapy , Gum Arabic/therapeutic use , Phytotherapy , Adult , Analysis of Variance , Chlorhexidine/therapeutic use , Colony Count, Microbial , Dental Plaque/microbiology , Dental Plaque Index , Gingivitis/microbiology , Humans , Male , Periodontal Index , Plant Preparations/therapeutic use
18.
Eur J Pediatr Surg ; 22(3): 234-7, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22576305

ABSTRACT

INTRODUCTION: The creation of a stoma on the abdomen and the need for appliance on the peristomal skin make this region vulnerable to inflammatory skin disorders. In this study, we introduce a novel protection with Acacia senegal and compare the protective effects of this barrier with zinc sulfate ointment. METHODS AND MATERIALS: To examine the effect of protective interventions, a prospective, controlled, clinical study was conducted. Participants were all infants consecutively admitted to the pediatric surgery unit of the study hospitals for elective surgery of colostomy creation. After laparotomy and double barrel colostomy creation, patients were randomly assigned to use one barrier (gum acacia or zinc sulfate ointment) for 4 weeks. RESULTS: In this study, a total of 60 infants (30 as case and 30 as control) were evaluated. Results showed that there was a statistically significant difference in peristomal skin inflammation rate in groups; infants who had Acacia senegal barrier showed lower and less sever inflammation rates (p=0.05). CONCLUSION: Compared with zinc oxide, we found a lower rate of dermatitis in the Acacia group.


Subject(s)
Abdominal Wall/surgery , Colostomy , Dermatitis/prevention & control , Gum Arabic/therapeutic use , Phytotherapy , Surgical Stomas/adverse effects , Dermatitis/drug therapy , Dermatologic Agents/therapeutic use , Female , Humans , Infant, Newborn , Male , Ointments , Prospective Studies , Statistics, Nonparametric , Zinc Sulfate/therapeutic use
19.
Ren Fail ; 34(1): 73-82, 2012.
Article in English | MEDLINE | ID: mdl-22017619

ABSTRACT

This study was conducted to evaluate the effects of Zingiber officinale Roscoe (Ginger), Arabic gum (AG), and Boswellia on both acute and chronic renal failure (CRF) and the mechanisms underlying their effects. Acute renal failure was induced by 30 min ischemia followed by 24 h reperfusion, while CRF was induced by adenine feeding for 8 weeks. Prophylactic oral administration of ginger, AG, Boswellia, or vehicle (in control groups) was started 3 days before and along with adenine feeding in different groups or 7 days before ischemia-reperfusion. Ginger and AG showed renoprotective effects in both models of renal failure. These protective effects may be attributed at least in part to their anti-inflammatory properties as evident by attenuating serum C-reactive protein levels and antioxidant effects as evident by attenuating lipid peroxidation marker, malondialdehyde levels, and increasing renal superoxide dismutase activity. Ginger was more potent than AG in both models of renal failure. However, Boswellia showed only partial protective effect against both acute renal failure and CRF and it had no antioxidant effects. Finally, we can say that ginger and AG could be beneficial adjuvant therapy in patients with acute renal failure and CRF to prevent disease progression and delay the need for renal replacement therapy.


Subject(s)
Acute Kidney Injury/drug therapy , Boswellia , Gum Arabic/therapeutic use , Kidney Failure, Chronic/drug therapy , Phytotherapy , Zingiber officinale , Animals , Male , Rats
20.
Exp Biol Med (Maywood) ; 236(1): 107-12, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21239740

ABSTRACT

Chronic renal failure (CRF) either occurring naturally in humans or induced surgically in rats causes alterations in behavior and motor functions. However, the effect of chemically induced CRF in rats on behavior is not known. We induced CRF in rats by feeding adenine (0.75% w/w, four weeks) and investigated the effect of the ensuing CRF on a depression model (forced swimming test, FST), analgesia (mechanical nociception), neuromuscular coordination (Rota-rod test) and motor activity (activity meter test). Further, we investigated the effect of giving acacia gum (AG, 10% w/v) in the drinking water concomitantly with adenine using the above models. AG has been previously shown to ameliorate the severity of CRF in humans and rats. Adenine-induced CRF significantly increased the plasma concentrations of urea and creatinine, and reduced creatinine clearance. Additionally, it significantly reduced motor activity and increased immobility time in the FST, suggesting a depressant-like effect. Both of these actions were significantly antagonized by AG treatment. Adenine insignificantly reduced the mechanical nociceptive threshold by 15%. The results of the tests for neuromuscular coordination were inconclusive. In conclusion, adenine-induced CRF caused motor and behavioral alterations, and these were significantly mitigated by administration of AG.


Subject(s)
Gum Arabic/therapeutic use , Kidney Failure, Chronic/drug therapy , Motor Activity/drug effects , Adenine/pharmacology , Animals , Body Weight/drug effects , Creatinine/blood , Depression/drug therapy , Depression/etiology , Depression/physiopathology , Drinking/drug effects , Kidney Failure, Chronic/chemically induced , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/physiopathology , Male , Motor Activity/physiology , Pain Measurement/drug effects , Psychomotor Performance/drug effects , Psychomotor Performance/physiology , Rats , Rats, Wistar , Urea/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...